ATL1 Gene SPG3A Genetic Test sale cost 4400 AED
RAI1 Gene Smith-Magenis Syndrome Genetic Test sale cost 4400 AED RAI1 Gene Smith-Magenis Syndrome Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
C12ORF65 Gene SPG55 Genetic Test sale cost 4400 AED C12ORF65 Gene SPG55 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

ATL1 Gene SPG3A Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ATL1 gene SPG3A genetic test is a specialized diagnostic tool designed to identify mutations in the ATL1 gene, which are known to cause a form of hereditary spastic paraplegia (HSP) known as SPG3A. This condition is characterized by progressive stiffness and weakness in the legs due to the degeneration of nerve pathways responsible for movement control. Early detection through genetic testing can be crucial for managing symptoms, planning treatment strategies, and understanding the risk of passing the condition to future generations.

DNA Labs UAE offers this specific genetic test, providing a comprehensive analysis of the ATL1 gene to identify any mutations associated with SPG3A. The test is priced at 4400 AED and is conducted in a state-of-the-art laboratory facility, ensuring high accuracy and reliability of the results. Individuals who have a family history of HSP or exhibit symptoms related to the condition may consider undergoing this test for a clear diagnosis. The results can also offer valuable insights for families planning children and looking to assess genetic risks.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ATL1 Gene SPG3A Genetic Test

Welcome to DNA Labs UAE, where we offer the ATL1 Gene SPG3A Genetic Test. This test is designed to identify mutations or variants in the ATL1 gene that may be responsible for hereditary spastic paraplegia (HSP) known as SPG3A. HSP is a group of genetic disorders characterized by progressive weakness and stiffness of the legs.

Test Details

The ATL1 gene, also known as SPG3A, is associated with SPG3A. Our NGS (Next-Generation Sequencing) genetic test analyzes the DNA sequence of the ATL1 gene to look for any abnormalities. The test can confirm a diagnosis of SPG3A and provide information about the specific mutation or variant in the ATL1 gene.

Test Components and Price

  • Components: ATL1 Gene SPG3A Genetic Test
  • Price: 4400.0 AED

Sample Condition

We accept the following sample conditions:

  • Blood
  • Extracted DNA
  • One drop of blood on FTA Card

Report Delivery

Our report delivery time is 3 to 4 weeks.

Method

We use NGS (Next-Generation Sequencing) technology for this genetic test.

Test Type

This test is specifically designed for Neurological Disorders.

Doctor and Test Department

Our test is conducted by a Neurologist and falls under the Genetics department.

Pre Test Information

Prior to the test, it is important to provide the clinical history of the patient who is going for the ATL1 Gene SPG3A NGS Genetic DNA Test. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with ATL1 Gene SPG3A.

Importance of Genetic Testing for SPG3A

Genetic testing for SPG3A can provide valuable information for genetic counseling, determining the inheritance pattern of the condition, and potentially guiding treatment options. However, it is crucial to have the test conducted by a qualified healthcare professional or genetic counselor who can provide appropriate guidance and interpretation of the results.

Test Name ATL1 Gene SPG3A Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ATL1 Gene SPG3A NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ATL1 Gene SPG3A
Test Details

The ATL1 gene, also known as SPG3A, is associated with a form of hereditary spastic paraplegia (HSP) called SPG3A. HSP is a group of genetic disorders characterized by progressive weakness and spasticity (stiffness) of the legs.

An NGS (Next-Generation Sequencing) genetic test for the ATL1 gene can be used to identify mutations or variants in the gene that may be responsible for SPG3A. This type of test analyzes the DNA sequence of the gene to look for any abnormalities.

The results of the genetic test can help in confirming a diagnosis of SPG3A and can also provide information about the specific mutation or variant in the ATL1 gene. This information can be useful for genetic counseling, determining the inheritance pattern of the condition, and potentially guiding treatment options.

It is important to note that genetic testing for SPG3A should be conducted by a qualified healthcare professional or genetic counselor, as they can provide appropriate guidance and interpretation of the results.

SKU: TEST-2005